Search

everythinglearnresearchcommunity

for

Search:↓

An 87-year-old man showed unusual signs of Hodgkin lymphoma, primarily high calcium levels, which improved after treatment and revealed the disease.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Gray hair can potentially be reversed, leading to new treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Some chemicals and drugs can cause hair loss, which usually grows back after stopping the treatment.

The model and estimator can predict drug exposure in kidney transplant patients well.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Adding a second method to PROTACs could improve cancer treatment.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Acitretin treatment unexpectedly darkened a patient's gray hair.

Lamivudine might reverse hair graying and needs more research for potential treatments.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.